Order Article Reprints

Clauß O, Schäker-Hübner L, Wenzel B, Toussaint M, Deuther-Conrad W, Gündel D, Teodoro R, Dukić-Stefanović S, Ludwig F-A, Kopka K, et al. Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [¹⁸F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain. Pharmaceuticals. 2022; 15(3):324. https://doi.org/10.3390/ph15030324

Clauß, Oliver, Linda Schäker-Hübner, Barbara Wenzel, Magali Toussaint, Winnie Deuther-Conrad, Daniel Gündel, Rodrigo Teodoro, Sladjana Dukić-Stefanović, Friedrich-Alexander Ludwig, Klaus Kopka, and et al. 2022. "Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [¹⁸F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain" Pharmaceuticals 15, no. 3: 324. https://doi.org/10.3390/ph15030324

Clauß, O., Schäker-Hübner, L., Wenzel, B., Toussaint, M., Deuther-Conrad, W., Gündel, D., Teodoro, R., Dukić-Stefanović, S., Ludwig, F.-A., Kopka, K., Brust, P., Hansen, F. K., & Scheunemann, M. (2022). Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [¹⁸F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain. Pharmaceuticals, 15(3), 324. https://doi.org/10.3390/ph15030324